Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant...

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Antibiotic resistance, particularly from multidrug-resistant (MDR) bacteria, poses a significant global health threat.
• Polymyxins are crucial last-line antibiotics for treating Gram-negative infections, but rising resistance limits their use.
• Bacterial resistance to polymyxins often involves modifying the lipid A component of the outer membrane with phosphoethanolamine (PEA) moieties.

Purpose of the Study:

• To provide a comprehensive review of phosphoethanolamine (PEA) transferases in pathogenic Gram-negative bacteria.
• To elucidate the function, structure, and mechanism of action of these PEA transferases.
• To summarize drug development efforts targeting PEA transferases for combating antibiotic resistance.

Main Methods:

• Literature review of studies on PEA transferases in Gram-negative bacteria.
• Analysis of enzyme structures and biochemical mechanisms.
• Survey of current drug development pipelines targeting PEA transferases.

Main Results:

• Gram-negative bacteria utilize PEA transferases not only for lipid A modification but also for decorating proteins and glycans.
• Understanding the diverse roles and mechanisms of PEA transferases is key to developing novel therapeutic strategies.
• Several drug development programs are actively pursuing inhibitors of PEA transferases.

Conclusions:

• PEA transferases represent a promising target family for reversing polymyxin resistance.
• Inhibiting these enzymes could restore the efficacy of polymyxins, enhancing their utility in empirical therapy.
• Targeting PEA transferases offers a viable strategy to combat the growing challenge of multidrug-resistant Gram-negative infections.